Table 1 Preoperative patient characteristics

Number

155 (100)

95 (100)

Age (year)

66 (62–69)

67 (63–71)

0.197

PSA (ng/ml)

6.4 (5.0–8.6)

7.8 (5.9–11.8)

<0.001

PSA density (ng/ml/cc)

0.184 (0.136–0.259)

0.221 (0.170–0.332)

<0.001

Number of biopsy core (n)

20 (14–20)

18 (14–20)

0.127

Number of positive core (n)

3 (2–5)

4 (2–6)

0.006

% of positive cores (%)

16.7 (9.3–27.3)

21.4 (14.0–35.0)

0.001

% of positive cores dominant side (%)

30.0 (14.3–42.9)

37.5 (20.0–57.1)

0.001

% of cancer extent (%)

42.7 (21.4–66.7)

50.0 (28.3–70.0)

0.055

 5–7

155 (100)

15 (15.8)

<0.001

 8–9

0 (0)

80 (84.2)

 cT1

118 (76.1)

60 (63.2)

0.035

 cT2a-c

37 (23.9)

33 (35.6)

 cT3a-b

0 (0)

2 (1.2)

 NA

0 (0)

1 (1.1)

<0.001

 cT1

51 (32.9)

22 (23.2)

 cT2a-c

104 (67.1)

58 (61.1)

 cT3a-b

0 (0)

14 (14.7)